Evaluating Acute Myeloid Leukemia Induction Regimens in Elderly Patients with Unfavorable Risk Cytogenetics That Are Candidates for Intensive Remission Therapy

Publication Date

2020

Presented At:

62nd ASH Annual Meeting

Content Type

Presentation

Publisher's Site:

View at Publisher Website

This document is currently not available here.

Share

COinS